Výsledky vyhledávání - "Scott P. Lankford"

External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort

Autor: Katherine R. Miller, Robert H. Press, Roshan S. Prabhu, C. Fasola, Anthony L. Asher, Danielle Boselli, Hui-Kuo Shu, R.J. McCammon, John H. Heinzerling, Kirtesh R. Patel, Scott P. Lankford, Ashley Sumrall, Walter J. Curran, Stuart H. Burri, Benjamin J. Moeller

Publikováno v: Journal of Neuro-Oncology. 137:147-154

Patients treated with stereotactic radiosurgery (SRS) for brain metastases (BM) are at increased risk of distant brain failure (DBF). Two nomograms have been recently published to predict individualized risk of DBF after SRS. The goal of this study w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb0aea5e1a9b335d85841113a824b5f
https://doi.org/10.1007/s11060-017-2707-2

Zobrazit plný text záznamu

Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis

Autor: Robert McCammon, Carolina E. Fasola, Walter J. Curran, Danielle Boselli, Anthony L. Asher, Hui-Kuo Shu, Robert H. Press, James T. Symanowski, Stuart H. Burri, Ashley Sumrall, Scott P. Lankford, Kirtesh R. Patel, Roshan S. Prabhu, Benjamin J. Moeller, Zachary S. Buchwald, John H. Heinzerling, Ian R. Crocker

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 99:459-467

Purpose Stereotactic radiosurgery (SRS) dose is limited by brain metastasis (BM) size. The study goal was to retrospectively determine whether there is a benefit for intracranial outcomes and overall survival (OS) for gross total resection with singl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9e997554786428ba2a291ba681dafa
https://doi.org/10.1016/j.ijrobp.2017.04.006

Zobrazit plný text záznamu

Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm

Autor: John H. Heinzerling, Robert H. Press, Carolina E. Fasola, Scott P. Lankford, Benjamin J. Moeller, Ashley Sumrall, Robert McCammon, Katherine R. Miller, Anthony L. Asher, Stuart H. Burri, Matthew C. Ward, Roshan S. Prabhu, Kirtesh R. Patel

Publikováno v: Journal of neurosurgery.

OBJECTIVEPreoperative stereotactic radiosurgery (SRS) is a feasible alternative to postoperative SRS and may lower the risk of radiation necrosis (RN) and leptomeningeal disease (LMD) recurrence. The study goal was to report the efficacy and toxicity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef9db0991a08ecb92f78bdb03dd6a2f
https://pubmed.ncbi.nlm.nih.gov/30554174

Zobrazit plný text záznamu

External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases

Autor: Hui-Kuo Shu, Benjamin J. Moeller, Stuart H. Burri, Robert H. Press, R.J. McCammon, Scott P. Lankford, Anthony L. Asher, Ashley Sumrall, C. Fasola, Danielle Boselli, Ian R. Crocker, John H. Heinzerling, James T. Symanowski, Kirtesh R. Patel, Walter J. Curran, Roshan S. Prabhu

Publikováno v: International journal of radiation oncology, biology, physics. 98(3)

Background A scoring system using pre-treatment factors was recently published ( Press et al., Cancer 2015) for predicting risk of early (≤6 months) distant brain failure (DBF) and salvage whole brain radiotherapy (WBRT) after stereotactic radiosur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e808100779c0d7dca0c8f589350ab7c
https://pubmed.ncbi.nlm.nih.gov/28581405

Zobrazit plný text záznamu

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Autor: Dominic T. Moore, Garry Schwartz, David E. Morris, A. William Blackstock, Scott N. Gettinger, Roy H. Decker, W. Jeffrey Petty, Scott P. Lankford, Thomas E. Stinchcombe, Amir H. Khandani, Mark A. Socinski

Publikováno v: Journal of Clinical Oncology. 30:3953-3959

Purpose Bevacizumab and erlotinib have been shown to improve survival in stage IV non–small-cell lung cancer (NSCLC). This phase I/II trial was designed to incorporate these agents with induction and concurrent chemoradiotherapy in stage III NSCLC.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cf0dae56f4074f15318e836079b3f62
https://doi.org/10.1200/jco.2012.41.9820

Zobrazit plný text záznamu

Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy

Autor: Alan Pollack, Scott P. Lankford, Gunar K. Zagars, Andrew C. von Eschenbach, Fady Geara, Robert H. Liebross

Publikováno v: Cancer. 85:1577-1585

BACKGROUND Despite its subjectivity and inaccuracy, digital rectal examination (DRE) has a long history of well-documented prognostic significance in patients with prostate carcinoma. To the authors' knowledge, very few studies have evaluated the rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b40a58c247d29197757734ad642c216
https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1577::aid-cncr20>3.0.co

Zobrazit plný text záznamu

Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy

Autor: Alan Pollack, Robert H. Liebross, Scott P. Lankford, Andrew C. von Eschenbach, Gunar K. Zagars

Publikováno v: Urology. 52:647-652

Objectives. The strict definition of Stage T1c prostate cancer is that the tumor is not palpable on digital rectal examination (DRE) or seen on imaging studies such as ultrasound. The inclusion of ultrasound imaging was brought about without an under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155c4cc1e7a319173ed08106a232a41d
https://doi.org/10.1016/s0090-4295(98)00273-8

Zobrazit plný text záznamu

Prostate-specific antigen cancer volume: A significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy

Autor: Alan Pollack, Gunar K. Zagars, Scott P. Lankford

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 38:327-333

Purpose: Although the pretreatment serum prostate-specific antigen level (PSAL) is the single-most significant predictor of local and biochemical control in prostate cancer patients treated with radiotherapy, it is relatively insensitive for patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25306c2b5e301274dc274f29527ac119
https://doi.org/10.1016/s0360-3016(96)00627-x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání